BPA replacement also interferes with the endocrine system at low doses

New study shows that BPS, a BPA replacement, leads to cell proliferation at low doses and interferes with normal estradiol induced signaling pathways

US EPA to publish a state of the science report on endocrine disruptors by the end of 2013

The US EPA responds to rising public and scientific concern regarding low-dose, hormone-like chemicals with a new state-of-the-science report scheduled for the end of 2013.

Nature: scientists claim effects at very low dose, regulators are not yet convinced

Researchers are discovering low-dose effects of endocrine disruptors since the seventies yet the issue remains a controversy and chemical regulation remains to be modified

Low dose experts meet in Berlin

Experts unite in Berlin to discuss low dose effects and non-monotonic dose response curves

Scientists meet in Berlin 11-13 September

Experts meet in Berlin 11-13 September to discuss low dose effects and non-monotonic dose responses